Emre Özgür1, Metin Keskin2, Ebru E Yörüker1, Stefan Holdenrieder3, Ugur Gezer4. 1. Department of Basic Oncology at Oncology Institute, Istanbul University, Istanbul, Turkey. 2. Department of General Surgery, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey. 3. Department of Laboratory Medicine, German Heart Center at Munich Technical University, Munich, Germany. 4. Department of Basic Oncology at Oncology Institute, Istanbul University, Istanbul, Turkey ugurd@istanbul.edu.tr.
Abstract
BACKGROUND/AIM: No blood-based biomarkers are available to differentiate between colonic tumors and precancerous polyps. Previously we demonstrated levels of trimethylated H4K20 (H4K20me3) to be lower in blood plasma from patients with colon cancer than those from cancer-free individuals. Herein, we added individuals with precancerous polyps for the first time in order to analyze and investigate the usefulness of plasma H4K20me3 and histone H4 to discriminate colon tumors from precancerous polyps. MATERIALS AND METHODS: The study included a cohort of 185 individuals undergoing colonoscopy. H4K20me3 and histone H4, measured by an enzyme-linked immunosorbent assay-like assay in plasma, were analyzed according to colonoscopy findings. RESULTS: Levels of H4K20me3 were lower in patients with colon cancer than in individuals with normal colonoscopy and those with precancerous polyps (p=0.02 and p=0.01, respectively). In contrast, highest quantities of histone H4 were measured in those with colon cancer compared to other groups (all p<0.01). CONCLUSION: Beside H4K20me3, plasma histone H4 is a useful marker to discriminate colonic tumors from precancerous polyps and other conditions. Copyright
BACKGROUND/AIM: No blood-based biomarkers are available to differentiate between colonic tumors and precancerous polyps. Previously we demonstrated levels of trimethylated H4K20 (H4K20me3) to be lower in blood plasma from patients with colon cancer than those from cancer-free individuals. Herein, we added individuals with precancerous polyps for the first time in order to analyze and investigate the usefulness of plasma H4K20me3 and histone H4 to discriminate colon tumors from precancerous polyps. MATERIALS AND METHODS: The study included a cohort of 185 individuals undergoing colonoscopy. H4K20me3 and histone H4, measured by an enzyme-linked immunosorbent assay-like assay in plasma, were analyzed according to colonoscopy findings. RESULTS: Levels of H4K20me3 were lower in patients with colon cancer than in individuals with normal colonoscopy and those with precancerous polyps (p=0.02 and p=0.01, respectively). In contrast, highest quantities of histone H4 were measured in those with colon cancer compared to other groups (all p<0.01). CONCLUSION: Beside H4K20me3, plasma histone H4 is a useful marker to discriminate colonic tumors from precancerous polyps and other conditions. Copyright
Authors: Mari Øines; Lise M Helsingen; Michael Bretthauer; Louise Emilsson Journal: Best Pract Res Clin Gastroenterol Date: 2017-06-28 Impact factor: 3.043
Authors: Mario F Fraga; Esteban Ballestar; Ana Villar-Garea; Manuel Boix-Chornet; Jesus Espada; Gunnar Schotta; Tiziana Bonaldi; Claire Haydon; Santiago Ropero; Kevin Petrie; N Gopalakrishna Iyer; Alberto Pérez-Rosado; Enrique Calvo; Juan A Lopez; Amparo Cano; Maria J Calasanz; Dolors Colomer; Miguel Angel Piris; Natalie Ahn; Axel Imhof; Carlos Caldas; Thomas Jenuwein; Manel Esteller Journal: Nat Genet Date: 2005-03-13 Impact factor: 38.330
Authors: Arnaud Van Den Broeck; Elisabeth Brambilla; Denis Moro-Sibilot; Sylvie Lantuejoul; Christian Brambilla; Beatrice Eymin; Sylvie Gazzeri Journal: Clin Cancer Res Date: 2008-10-30 Impact factor: 12.531